Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 146
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07521670 | Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP) | ||
| NCT05929885 | Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients | ||
| NCT03233360 | Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry | ||
| NCT04632173 | Head and Neck cancERs International cOviD-19 collabOraTion | ||
| NCT05377034 | Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients | ||
| NCT01341834 | Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors | ||
| NCT04224480 | Longitudinal Immune-phenotyping of HCC Following MK-3475 | ||
| NCT03430128 | Perioperative Immunonutrition for Patients Undergoing CRS and HIPEC | ||
| NCT05724264 | SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE) | ||
| NCT04912765 | Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC | ||
| NCT02559336 | Pilot Study of the SPaRK (Supportive and Palliative Care Review Kit) Model of Care for Advanced Cancer Patients Who Have an Unplanned Admission to Singapore General Hospital | ||
| NCT06160843 | Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma | ||
| NCT05059340 | Study to Explore Post Surgical Outcomes Using Point-of-Gaze, Electromyography and Elastography of the SCM | ||
| NCT00997906 | Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC | ||
| NCT03033446 | Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma | ||
| NCT06418412 | A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC | ||
| NCT00467194 | Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | ||
| NCT04956068 | PIPAC for Peritoneal Metastases | ||
| NCT04961632 | Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376 | ||
| NCT05198479 | Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in | ||
| NCT04664829 | The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC | ||
| NCT03515174 | Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO | ||
| NCT02435927 | ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin | ||
| NCT03670342 | Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer | ||
| NCT03212807 | Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL | ||
| NCT04087473 | Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC | ||
| NCT02801734 | Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer | ||
| NCT05355558 | A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix Cancer | ||
| NCT03212937 | Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphoma | ||
| NCT00486213 | Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer | ||
| NCT03097939 | Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma | ||
| NCT07583979 | Electroacupuncture for Cognitive Toxicity in Cancer Survivors: Assessing Implementation, Cost, and Effectiveness for Integration | ||
| NCT02736305 | Use of Regorafenib in Recurrent Epithelial Ovarian Cancer | ||
| NCT02548039 | To Study The Influence Of Genomic Factors On Metabolism And Effects Of Clomiphene In Asian Normogonadotrophic Anovulatory Patients. | ||
| NCT01865838 | A Study Into the Effect of Seprafilm in Open Total Thyroidectomy | ||
| NCT03200730 | A Novel Family Dignity Intervention (FDI) for Asian Palliative Care | ||
| NCT02412267 | Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL) | ||
| NCT02808091 | Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma | ||
| NCT03792867 | Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma | ||
| NCT01022723 | Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells | ||
| NCT00702182 | Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer | ||
| NCT01716689 | Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas | ||
| NCT04104113 | Health-related Quality of Life-intervention in Survivors of Breast and Other Cancers Experiencing Cancer-related Fatigue Using Traditional Chinese Medicine: The HERBAL Trial | ||
| NCT04072107 | EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR) | ||
| NCT06044441 | Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG) | ||
| NCT04025515 | Molecular Profiling Project | ||
| NCT04946968 | Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers | ||
| NCT06766058 | Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy. | ||
| NCT00565708 | Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers | ||
| NCT01100801 | A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients |
